-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00294.74% Upside
Anebulo Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Anebulo Pharmaceuticals, Inc.?
Anebulo Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright in the past 90 days.